Have a feature idea you'd love to see implemented?
Let us know!
FLGT Fulgent Genetics Inc
Price (delayed)
$19.15
Market cap
$580.18M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.48
Enterprise value
$515.48M
Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high
Highlights
Fulgent Genetics's debt has plunged by 91% YoY
FLGT's gross margin is up by 22% year-on-year and by 4.3% since the previous quarter
FLGT's quick ratio is down by 36% year-on-year but it is up by 3.2% since the previous quarter
The company's equity fell by 10% YoY
Fulgent Genetics's revenue has decreased by 5% YoY
Key stats
What are the main financial stats of FLGT
Market
Valuations
Earnings
Shares outstanding
30.3M
Market cap
$580.18M
Enterprise value
$515.48M
Price to book (P/B)
0.51
Price to sales (P/S)
1.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.77
Revenue
$290.71M
EBIT
-$156.42M
EBITDA
-$124.82M
Free cash flow
$12.33M
Per share
Balance sheet
Liquidity
EPS
-$5.48
Free cash flow per share
$0.41
Book value per share
$37.85
Revenue per share
$9.66
TBVPS
$35.59
Total assets
$1.23B
Total liabilities
$103.39M
Debt
$412,000
Equity
$1.13B
Working capital
$323.35M
Debt to equity
0
Current ratio
5.27
Quick ratio
4.86
Net debt/EBITDA
0.52
Margins
Efficiency
Dividend
EBITDA margin
-42.9%
Gross margin
39.1%
Net margin
-56.2%
Operating margin
-65.9%
Return on assets
-12.9%
Return on equity
-14%
Return on invested capital
-16.9%
Return on capital employed
-13.5%
Return on sales
-53.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
FLGT stock price
How has the Fulgent Genetics stock price performed over time
Intraday
-0.16%
1 week
-2.59%
1 month
-10.56%
1 year
-24.34%
YTD
-33.76%
QTD
-11.87%
Financial performance
How have Fulgent Genetics's revenue and profit performed over time
Revenue
$290.71M
Gross profit
$113.67M
Operating income
-$191.61M
Net income
-$163.43M
Gross margin
39.1%
Net margin
-56.2%
Fulgent Genetics's operating margin has plunged by 151% YoY
Fulgent Genetics's operating income has plunged by 137% YoY
FLGT's gross margin is up by 22% year-on-year and by 4.3% since the previous quarter
The gross profit has grown by 15% YoY and by 5% from the previous quarter
Growth
What is Fulgent Genetics's growth rate over time
Valuation
What is Fulgent Genetics stock price valuation
P/E
N/A
P/B
0.51
P/S
1.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.77
The price to book (P/B) is 73% lower than the 5-year quarterly average of 1.9 and 15% lower than the last 4 quarters average of 0.6
The company's equity fell by 10% YoY
FLGT's P/S is 43% below its 5-year quarterly average of 3.5 and 21% below its last 4 quarters average of 2.5
Fulgent Genetics's revenue has decreased by 5% YoY
Efficiency
How efficient is Fulgent Genetics business performance
FLGT's ROS has dropped by 150% year-on-year but it is up by 3.2% since the previous quarter
The company's return on invested capital has shrunk by 145% YoY
Dividends
What is FLGT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for FLGT.
Financial health
How did Fulgent Genetics financials performed over time
FLGT's quick ratio is down by 36% year-on-year but it is up by 3.2% since the previous quarter
FLGT's current ratio is down by 35% year-on-year but it is up by 3.5% since the previous quarter
Fulgent Genetics's debt is 100% less than its equity
Fulgent Genetics's debt has plunged by 91% YoY
The company's equity fell by 10% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.